Table 4.

Treatment-emergent adverse events reported for > 4 patients─Cohorts 1 and 2.

Event	Number of patients [%]
Any adverse event	46 [93.9]
Gastrointestinal	17 [34.7]
Abdominal pain	5 [10.2]
General/site	15 [30.6]
Fatigue	6 [12.2]
Infections and infestations	21 [42.9]
Nasopharyngitis	8 [16.3]
Musculoskeletal and connective tissue	16 [32.7]
Arthralgia	9 [18.4]
Nervous system	9 [18.4]
Headache	6 [12.2]